Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Microflora in colorectal cancer: a friend to fear.

Fukata M, Abreu MT.

Nat Med. 2010 Jun;16(6):639-41. doi: 10.1038/nm0610-639. No abstract available.

PMID:
20526315
2.

ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.

Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, Herdman S, Varki N, Corr M, Lee J, Raz E.

Nat Med. 2010 Jun;16(6):665-70. doi: 10.1038/nm.2143. Epub 2010 May 9.

3.

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88.

Rakoff-Nahoum S, Medzhitov R.

Science. 2007 Jul 6;317(5834):124-7.

4.

"Hot spots" can burn you.

Wills JC, Kuwada SK, Burt RW.

Am J Gastroenterol. 2002 Mar;97(3):757-8. Review. No abstract available.

PMID:
11922576
5.

Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.

Yamaguchi K, Cekanova M, McEntee MF, Yoon JH, Fischer SM, Renes IB, Van Seuningen I, Baek SJ.

Mol Cancer Ther. 2008 Sep;7(9):2779-87. doi: 10.1158/1535-7163.MCT-08-0173.

6.

Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.

Shattuck-Brandt RL, Lamps LW, Heppner Goss KJ, DuBois RN, Matrisian LM.

Mol Carcinog. 1999 Mar;24(3):177-87.

PMID:
10204802
7.

Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice.

Segditsas S, Sieber O, Deheragoda M, East P, Rowan A, Jeffery R, Nye E, Clark S, Spencer-Dene B, Stamp G, Poulsom R, Suraweera N, Silver A, Ilyas M, Tomlinson I.

Hum Mol Genet. 2008 Dec 15;17(24):3864-75. doi: 10.1093/hmg/ddn286. Epub 2008 Sep 9.

8.

Haploinsufficiency of Kr├╝ppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine.

McConnell BB, Bialkowska AB, Nandan MO, Ghaleb AM, Gordon FJ, Yang VW.

Cancer Res. 2009 May 15;69(10):4125-33. doi: 10.1158/0008-5472.CAN-08-4402. Epub 2009 May 12.

9.

BCL9-2 promotes early stages of intestinal tumor progression.

Brembeck FH, Wiese M, Zatula N, Grigoryan T, Dai Y, Fritzmann J, Birchmeier W.

Gastroenterology. 2011 Oct;141(4):1359-70, 1370.e1-3. doi: 10.1053/j.gastro.2011.06.039. Epub 2011 Jun 23.

PMID:
21703997
10.

Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.

Sansom OJ, Meniel V, Wilkins JA, Cole AM, Oien KA, Marsh V, Jamieson TJ, Guerra C, Ashton GH, Barbacid M, Clarke AR.

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14122-7. Epub 2006 Sep 7.

11.

Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.

Pack SC, Kim HR, Lim SW, Kim HY, Ko JY, Lee KS, Hwang D, Park SI, Kang H, Park SW, Hong GY, Hwang SM, Shin MG, Lee S.

Int J Colorectal Dis. 2013 Jan;28(1):139-47. doi: 10.1007/s00384-012-1566-8. Epub 2012 Sep 19.

PMID:
22990173
12.

The role of folic acid and vitamin B12 in colorectal carcinogenesis in genetically different individuals--design of a study.

Van den Donk M, Pellis EP, Keijer J, Kok FJ, Nagengast FM, Kampman E.

IARC Sci Publ. 2002;156:499-500. No abstract available.

PMID:
12484242
13.

RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.

Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H, Ito Y.

Cancer Cell. 2008 Sep 9;14(3):226-37. doi: 10.1016/j.ccr.2008.08.004. Erratum in: Cancer Cell. 2009 Mar 3;15(3):240.

14.

AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene.

Mimura M, Masuda A, Nishiumi S, Kawakami K, Fujishima Y, Yoshie T, Mizuno S, Miki I, Ohno H, Hase K, Minamoto T, Azuma T, Yoshida M.

Int J Cancer. 2012 Mar 1;130(5):1011-20. doi: 10.1002/ijc.26131. Epub 2011 May 30.

15.

APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.

Stern HS, Viertelhausen S, Hunter AG, O'Rourke K, Cappelli M, Perras H, Serfas K, Blumenthall A, Dewar D, Baumann E, Lagarde AE.

Gastroenterology. 2001 Feb;120(2):392-400.

PMID:
11159880
16.

Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis.

Zhang L, Ren X, Alt E, Bai X, Huang S, Xu Z, Lynch PM, Moyer MP, Wen XF, Wu X.

Nature. 2010 Apr 15;464(7291):1058-61. doi: 10.1038/nature08871. Epub 2010 Mar 28.

17.

Elevated risk for colorectal neoplasms among first-degree relatives of patients with colorectal adenomatous polyps.

Nakama H, Fukuzawa K.

Dig Liver Dis. 2001 Aug-Sep;33(6):504. No abstract available.

PMID:
11572581
18.

Risk of colorectal cancer in families of patients with adenomatous polyps.

Zarchy TM, Ershoff D.

N Engl J Med. 1996 May 16;334(20):1339-40. No abstract available.

19.

Colorectal cancer prevention.

Kauh J, Umbreit J.

Curr Probl Cancer. 2004 Sep-Oct;28(5):240-64. Review. No abstract available.

PMID:
15375803
20.

Intestinal epithelial cell-specific CD98 expression regulates tumorigenesis in Apc(Min/+) mice.

Nguyen HT, Dalmasso G, Yan Y, Laroui H, Charania M, Ingersoll S, Ayyadurai S, Zhang Y, Sitaraman S, Merlin D.

Lab Invest. 2012 Aug;92(8):1203-12. doi: 10.1038/labinvest.2012.83. Epub 2012 May 28.

Supplemental Content

Support Center